Cargando…

Site‐specific Mutation of the Human c‐Ha‐ras Transgene Induced by Dimethylbenzanthracene Causes Tissue‐specific Tumors in Mice

Forestoraach squamous cell carcinomas, lung adenocarcinomas and spleen angiosarcomas were induced by dimethylbenzanthracene (DMBA) in the rasH2 transgenic mouse line carrying human c‐Ha‐ras genes with their own promoter, encoding the prototype p21 gene product. Fifteen out of 21 mice (71%) developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doi, Satoru‐Takahiro, Kimura, Minoru, Katsuki, Motoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919566/ https://www.ncbi.nlm.nih.gov/pubmed/7928625 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02951.x

Ejemplares similares

Rare Activation of the Human c‐Ha‐ras Transgene of Mice in Hemangioendothelial Sarcomas and Liver Tumors Induced by Glu‐P‐1
por: Inoue, Rie, et al.
Publicado: (1996)

The Effect of Hypophysectomy on the Development of Ovarian Tumours in Mice Treated with Dimethylbenzanthracene
por: Marchant, June
Publicado: (1961)

Carcinogenesis in the Pituitary Dwarf Mouse. The Response to Dimethylbenzanthracene Applied to the Skin
por: Bielschowsky, F., et al.
Publicado: (1961)

Chemical carcinogenesis by 7,12-dimethylbenzanthracene in balb/c mice
por: Tedardi, Marcello V, et al.
Publicado: (2013)

Ras signaling directs endothelial specification of VEGFR2(+) vascular progenitor cells
por: Kawasaki, Kyoko, et al.
Publicado: (2008)

Growth and therapy of mammary tumours induced by 7,12-dimethylbenzanthracene in rats.
por: Heise, E., et al.
Publicado: (1966)

Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model
por: Liu, Zhongbo, et al.
Publicado: (2014)

Cholestyramine promotes 7,12-dimethylbenzanthracene induced mammary cancer in Wistar rats.
por: Melhem, M. F., et al.
Publicado: (1987)

Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats
por: Jenkins, Sarah, et al.
Publicado: (2009)

The Development of Ovarian Tumours in Ovaries Grafted from Mice Pretreated with Dimethylbenzanthracene: Inhibition by the Presence of Normal Ovarian Tissue
por: Marchant, June
Publicado: (1960)

Different Mutation Frequencies and Spectra among Organs by N‐Methyl‐N‐nitrosourea in rpsL (strA) Transgenic Mice
por: Shioyama, Yoshiyuki, et al.
Publicado: (2000)

Effect of thymectomy on the induction of skin tumours by dibenzanthracene, and of breast tumours by dimethylbenzanthracene, in mice of the IF strain.
por: Johnson, S.
Publicado: (1968)

Transgenic Rats Carrying Human c‐Ha‐ras Proto‐oncogene Are Highly Susceptible to N‐Nitrosomethylbenzylamine Induction of Esophageal Tumorigenesis
por: Asamoto, Makoto, et al.
Publicado: (2002)

Transgenic HA-1-Specific CD8(+) T-Lymphocytes Selectively Target Leukemic Cells
por: Pilunov, Artem, et al.
Publicado: (2023)

Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice
por: Liu, Zhongbo, et al.
Publicado: (2022)

LYSOSOMAL PHYSIOLOGY IN TETRAHYMENA : III. Pharmacological Studies on Acid Hydrolase Release and the Ingestion and Egestion of Dimethylbenzanthracene Particles
por: Rothstein, Thomas L., et al.
Publicado: (1974)

Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma.
por: Czerniak, B., et al.
Publicado: (1990)

Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers.
por: Koh, E. H., et al.
Publicado: (1992)

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
por: Magaki, Mie, et al.
Publicado: (2016)

Oxidative Stress Posttranslationally Regulates the Expression of Ha-Ras and Ki-Ras in Cultured Astrocytes
por: Messina, Samantha, et al.
Publicado: (2012)

Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
por: Yamamoto, S, et al.
Publicado: (1998)

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
por: Makino, Yasuhide, et al.
Publicado: (2021)

RAS‐targeted cancer therapy: Advances in drugging specific mutations
por: Liu, Cen, et al.
Publicado: (2023)

Mammary Carcinomas Induced in Human c‐Ha‐ras Proto‐oncogene Transgenic Rats Are Estrogen‐independent, but Responsive to d‐Limonene Treatment
por: Asamoto, Makoto, et al.
Publicado: (2002)

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.
por: Arends, M. J., et al.
Publicado: (1993)

Ha-ras restriction fragment length polymorphisms in colorectal cancer.
por: Wyllie, F. S., et al.
Publicado: (1988)

Site–Specific Monoubiquitination Activates Ras by Impeding GTPase Activating Protein Function
por: Baker, Rachael, et al.
Publicado: (2012)

A system for site-specific integration of transgenes in mammalian cells
por: Chi, Xiuling, et al.
Publicado: (2019)

The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues
por: Berthelsen, Martin Fogtmann, et al.
Publicado: (2021)

Biokinetics and Subchronic Toxic Effects of Oral Arsenite, Arsenate, Monomethylarsonic Acid, and Dimethylarsinic Acid in v-Ha-ras Transgenic (Tg.AC) Mice
por: Xie, Yaxiong, et al.
Publicado: (2004)

Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts
por: Smaldone, Silvia, et al.
Publicado: (2011)

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide
Publicado: (1994)

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model
por: Singh, Alok R, et al.
Publicado: (2014)

Constitutional frequency of rare alleles of c-Ha-ras in breast cancer patients.
por: White, G. R., et al.
Publicado: (1988)

Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.
por: Ceccherini-Nelli, L., et al.
Publicado: (1987)

Transformation of NIH3T3 Cells with Synthetic c‐Ha‐ras Genes
por: Kamiya, Hiroyuki, et al.
Publicado: (1989)

Rosa26 Locus Supports Tissue-Specific Promoter Driving Transgene Expression Specifically in Pig
por: Kong, Qingran, et al.
Publicado: (2014)

Structure and applications of novel influenza HA tri-stalk protein for evaluation of HA stem-specific immunity
por: Lu, I-Na, et al.
Publicado: (2018)

Overexpression of DA41 in v‐Ha‐ras‐3Y1 Cells Causes Growth Suppression
por: Ozaki, Toshinori, et al.
Publicado: (2000)

Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1
por: Iwig, Jeffrey S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s40jfumnqh4pi3us3b93t7bfn9